Why PCVX? Vaxcyte, Inc. Analysis, Price & AI Insights | Whystock
PCVX
$56.93-0.31 (-0.54%)
Pre-Market$57.06+0.13 (+0.23%)· Last close May 1
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.